← Back to Search

Pulsed Lavage for Breast Reconstruction

N/A
Recruiting
Led By Prasanth Patcha, MD
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 months
Awards & highlights

Summary

This trial will study if pulsed lavage reduces post-op complications in breast reconstruction patients. Outcomes include SSI, hematoma, seroma, & implant failure.

Who is the study for?
This trial is for women aged 18-75 who are having breast reconstruction with a tissue expander right after mastectomy. They must understand and sign consent. It's not for those getting delayed reconstruction or men.Check my eligibility
What is being tested?
The study tests if pulsed lavage (a washing technique) during surgery can reduce complications like infections, fluid collections, and implant problems in immediate breast reconstruction after mastectomy.See study design
What are the potential side effects?
Potential side effects may include issues at the surgical site such as infection, hematoma (blood pooling), seroma (fluid buildup), or failure of the breast implant.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Post-op Complications

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Pulsed Lavage WashoutExperimental Treatment5 Interventions
This cohort will undergo standard of care bilateral or unilateral mastectomies as determined by breast surgical oncologists and immediate standard of care breast reconstruction with tissue expander placement and pulsed lavage washout.
Group II: No Pulsed LavageActive Control4 Interventions
This cohort will undergo standard of care bilateral or unilateral mastectomies as determined by breast surgical oncologists and immediate standard of care breast reconstruction with tissue expander placement.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Tissue expander
2017
Completed Phase 1
~20

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor
1,599 Previous Clinical Trials
2,287,858 Total Patients Enrolled
Prasanth Patcha, MDPrincipal InvestigatorUniversity of Alabama at Birmingham
Richard J Fix, MDPrincipal InvestigatorUniversity of Alabama at Birmingham

Media Library

Bilateral or unilateral mastectomy Clinical Trial Eligibility Overview. Trial Name: NCT05585710 — N/A
Breast Reconstruction Research Study Groups: Pulsed Lavage Washout, No Pulsed Lavage
Breast Reconstruction Clinical Trial 2023: Bilateral or unilateral mastectomy Highlights & Side Effects. Trial Name: NCT05585710 — N/A
Bilateral or unilateral mastectomy 2023 Treatment Timeline for Medical Study. Trial Name: NCT05585710 — N/A
~41 spots leftby Aug 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top